scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1 |
P698 | PubMed publication ID | 9714054 |
P2093 | author name string | H Inoue | |
M Namba | |||
K Mihara | |||
A Kawai | |||
M Miyazaki | |||
C Gao | |||
T Kunisada | |||
P2860 | cites work | p53, the cellular gatekeeper for growth and division | Q27860990 |
Rearrangement of the p53 gene in human osteogenic sarcomas | Q34360802 | ||
Effect of exogenous extracellular matrices on proteoglycan synthesis by cultured rabbit costal chondrocytes | Q36211502 | ||
Cartilage contains mixed fibrils of collagen types II, IX, and XI. | Q36219869 | ||
The collagens: an overview and update | Q39667067 | ||
Mutation in p53 and de-regulation of p53-related gene expression in three human cell lines immortalized with 4-nitroquinoline 1-oxide or 60Co gamma rays | Q41197403 | ||
Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene | Q41270274 | ||
p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas | Q42281236 | ||
Clonal analysis of the population of chondrocytes from the Swarm rat chondrosarcoma in agarose culture. | Q50912626 | ||
Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide. | Q53482595 | ||
Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading | Q67652553 | ||
Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone | Q68365252 | ||
Chondrosarcoma of bone in children | Q68546665 | ||
Borderline chondrosarcoma of long and flat bones | Q70601234 | ||
Influence of intralesional surgery on treatment outcome of chondrosarcoma | Q71018214 | ||
Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas | Q71019348 | ||
p53 expression in dedifferentiated chondrosarcoma | Q71067140 | ||
Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery | Q71394580 | ||
Expression of collagen species in a cartilaginous tumor derived from a human osteogenic sarcoma | Q72178671 | ||
Screening patients for heterozygous p53 mutations using a functional assay in yeast | Q72635302 | ||
Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen | Q72680655 | ||
A rapid banding technique for human chromosomes | Q93712955 | ||
P4510 | describes a project that uses | OUMS-27 | Q54936776 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
chondrosarcoma | Q1076087 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 854-859 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation | |
P478 | volume | 77 |
Q21710715 | A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation |
Q55670715 | A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis |
Q39413029 | A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus. |
Q82819973 | ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes |
Q37150809 | Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma |
Q39757107 | Accelerated Ca2+ entry by membrane hyperpolarization due to Ca2+-activated K+ channel activation in response to histamine in chondrocytes |
Q38946440 | An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing |
Q39295187 | Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes |
Q35841926 | Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro |
Q36840323 | Chondrosarcoma and peroxisome proliferator-activated receptor |
Q51609310 | Chondrosarcoma cell differentiation. |
Q73592730 | Chondrosarcoma is not characterized by detectable telomerase activity |
Q40181101 | Crosslinking of the CD69 molecule enhances S100A9 production in activated neutrophils |
Q53265964 | Direct anti-cancer effect of oncostatin M on chondrosarcoma. |
Q35870183 | Effect of insulin on the mRNA expression of procollagen N-proteinases in chondrosarcoma OUMS-27 cells |
Q40454254 | Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. |
Q36892224 | Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation |
Q28246205 | Expression and regulation of the osteoarthritis-associated protein asporin |
Q36023355 | Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo |
Q45861778 | Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma |
Q52668912 | GABAB receptor regulates proliferation in the high-grade chondrosarcoma cell line OUMS-27 via apoptotic pathways. |
Q93176343 | High LET Radiation Overcomes In Vitro Resistance to X-Rays of Chondrosarcoma Cell Lines |
Q40777982 | High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma |
Q40759573 | Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth |
Q64276482 | IL-10 Could Play a Role in the Interrelation between Diabetes Mellitus and Osteoarthritis |
Q28211981 | Identification and characterization of the human long form of Sox5 (L-SOX5) gene |
Q33596027 | Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis |
Q38283069 | Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma |
Q38884358 | Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. |
Q93105834 | New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth |
Q40561012 | New cell lines with chondrocytic phenotypes from human chondrosarcoma |
Q39108175 | New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. |
Q33986627 | New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis |
Q36078319 | No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone |
Q35652183 | Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP). |
Q38482549 | Premature chromosome condensation revisited: a novel chemical approach permits efficient cytogenetic analysis of cancers |
Q39467387 | RUNX2 expression in developing human bones and various bone tumors |
Q24336116 | Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription |
Q36190010 | Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome |
Q28138380 | Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo |
Q37185828 | Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells |
Q42419178 | Targeting survivin as a potential new treatment for chondrosarcoma of bone |
Q35865893 | The Investigation of ADAMTS16 in Insulin-Induced Human Chondrosarcoma Cells. |
Q47340434 | The Third European Growth Plate Working Group Symposium. 17th September 2003, Ljubljana, Slovenia |
Q39383794 | The phenotypic characterization of A13/BACii, a novel bovine chondrocytic cell line with differentiation potential |
Q34396287 | Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone |
Q54936776 | OUMS-27 | described by source | P1343 |
Search more.